These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 29978665)

  • 1. Patenting Nucleic Acid Sequences: More Ambiguity from the High Court?
    Lawson C
    J Law Med; 2018 Apr; 25(3):741-764. PubMed ID: 29978665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MYRIAD VOICES AGAINST GENE PATENTS IN THE HIGH COURT.
    McCallum L; Faunce T
    J Law Med; 2015 Dec; 23(2):322-9. PubMed ID: 26939499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Some Legal Issues Regarding the Patenting of Human Genetic Materials.
    MacFarlane P; Kontoleon B
    J Law Med; 2016; 24(1):181-202. PubMed ID: 30136781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Take off your genes and let the doctor have a look: why the Mayo and Myriad decisions have invalidated method claims for genetic diagnostic testing.
    Bergin C
    Am Univ Law Rev; 2013; 63(1):173-217. PubMed ID: 25335200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prometheus: the Supreme Court redefines the patentability of diagnostic inventions.
    Kumamoto A; Schmid CL
    Recent Pat DNA Gene Seq; 2012 Dec; 6(3):193-6. PubMed ID: 22812581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Some Legal Issues Regarding the Patenting of Human Genetic Materials.
    MacFarlane P; Kontoleon B
    J Law Med; 2016; 24(1):181-202. PubMed ID: 30136782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Grant v Commissioner of Patents and patenting knowledge inventions.
    Lawson C
    J Law Med; 2008 Feb; 15(4):626-43. PubMed ID: 18365526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene patents, patenting life and the impact of court rulings on US stem cell patents and research.
    Matthews KR; Cuchiara ML
    Regen Med; 2014 Mar; 9(2):191-200. PubMed ID: 24750060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patent portfolios after myriad, how to fit in those new genes?
    Aceto JF
    ACS Med Chem Lett; 2013 Aug; 4(8):681-3. PubMed ID: 24900729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An overview of a recent court challenge to the protection of biomarkers as intellectual property.
    Hall SC; Tromp JM; Jortani SA
    Clin Chim Acta; 2011 May; 412(11-12):802-5. PubMed ID: 21315704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patentability of genetically engineered microorganisms.
    Cooper A
    JAMA; 1983 Mar; 249(12):1553-4. PubMed ID: 6338261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patenting DNA.
    Bobrow M; Thomas S
    Curr Opin Mol Ther; 2002 Dec; 4(6):542-7. PubMed ID: 12596355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Something more is necessary: are genes and genetic diagnostic tests statutory subject matter for US patents?
    Cockbain J; Sterckx S
    Expert Rev Mol Diagn; 2011 Mar; 11(2):149-58. PubMed ID: 21405966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies for strengthening patent protection of pharmaceutical inventions in light of federal court decisions.
    Pillai X; Kinney WA
    Curr Top Med Chem; 2010; 10(18):1929-36. PubMed ID: 20615184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of Myriad on the Future Development and Commercialization of DNA-Based Therapies and Diagnostics.
    Wales M; Cartier E
    Cold Spring Harb Perspect Med; 2015 Sep; 5(12):. PubMed ID: 26337114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene patents and personalized cancer care: impact of the Myriad case on clinical oncology.
    Offit K; Bradbury A; Storm C; Merz JF; Noonan KE; Spence R
    J Clin Oncol; 2013 Jul; 31(21):2743-8. PubMed ID: 23766521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The end of DNA patents in the United States?
    Webber P
    Expert Opin Ther Pat; 2013 Dec; 23(12):1525-7. PubMed ID: 24138004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Competition policy in patent cases and antitrust.
    Sobel G
    Adv Genet; 2003; 50():23-64; discussion 507-10. PubMed ID: 14714685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patenting nature-a comparative perspective.
    Dreyfuss RC; Nielsen J; Nicol D
    J Law Biosci; 2018 Dec; 5(3):550-589. PubMed ID: 31143455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do recent US Supreme Court rulings on patenting of genes and genetic diagnostics affect the practice of genetic screening and diagnosis in prenatal and reproductive care?
    Chandrasekharan S; McGuire AL; Van den Veyver IB
    Prenat Diagn; 2014 Oct; 34(10):921-6. PubMed ID: 24989832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.